share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lagarde Michel

SEC announcement ·  May 3 16:23
Summary by Moomoo AI
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Michel Lagarde, a key figure at the company. The transaction, which took place on May 1, 2024, did not specify the relationship of Lagarde to the issuer. Details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares after the action were not disclosed in the announcement.
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Michel Lagarde, a key figure at the company. The transaction, which took place on May 1, 2024, did not specify the relationship of Lagarde to the issuer. Details regarding the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares after the action were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more